• Info
  • Insider Ownership

Insider Trading & Ownership of Jeffrey Poulton V.

Location
Cambridge, MA
Summary
The estimated net worth of Jeffrey Poulton V. is at least $20,920,825 dollars as of 06 Mar 2026. Jeffrey Poulton V. is the EVP, Chief Financial Officer of ALNYLAM PHARMACEUTICALS, INC. and owns shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY) stock worth about $20.61M. Jeffrey Poulton V. is the Director of Homology Medicines, Inc. and owns shares of Q32 Bio Inc. (QTTB) stock worth about $308.7K.
Signature
By: Brett Budzinski, Attorney-in-Fact For: Jeffrey V. Poulton
All Insider Reports
All Insider Reports

Notify me when Jeffrey Poulton V. files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Jeffrey Poulton V.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ALNY ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Financial Officer $20,612,165 -$5,982,129 -22% 04 Mar 2026
QTTB Homology Medicines, Inc. Director $308,660 14 Jun 2023
CRVO CervoMed Inc. Director 23 Jun 2025

Insider Transactions Reported by Jeffrey Poulton V.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.